Latest Articles
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network
Published: Jan. 20, 2025, 5:08 p.m.
Endometriosis: A Chronic Disease - MSN
Endometriosis: A Chronic Disease MSN
Published: Jan. 20, 2025, 3:22 p.m.
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
Gesynta Pharma Raises $29M to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Jan. 20, 2025, 10:56 a.m.
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment - beQuoted
Gesynta Pharma Raises SEK 304 Million to Advance Novel Endometriosis Treatment beQuoted
Published: Jan. 20, 2025, 8:21 a.m.
Dedicated endometriosis clinic fills care gap - Bdaily News
Dedicated endometriosis clinic fills care gap Bdaily News
Published: Jan. 20, 2025, 6:59 a.m.
Endometriosis poses substantial burden on Australia's health system - MSN
Endometriosis poses substantial burden on Australia's health system MSN
Published: Jan. 20, 2025, 6:23 a.m.
Mum discovers 16 fibroids following years of misdiagnosed menstrual pain - Surrey Live
Mum discovers 16 fibroids following years of misdiagnosed menstrual pain Surrey Live
Published: Jan. 20, 2025, 2:32 a.m.
Untreated painful periods can cost economy up to $14.2 billion per year - Women's Agenda
Untreated painful periods can cost economy up to $14.2 billion per year Women's Agenda
Published: Jan. 20, 2025, 1:08 a.m.
Study links higher microplastic levels in urine to endometriosis risk - MSN
Study links higher microplastic levels in urine to endometriosis risk MSN
Published: Jan. 20, 2025, 12:19 a.m.
The high cost of neglecting women’s health - Inquirer.net
The high cost of neglecting women’s health Inquirer.net
Published: Jan. 19, 2025, 8:20 p.m.
Link copied to clipboard!